• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Essity completes the acquisition of Edgewell's feminine care business

ESSITY BPress release2026-02-02 18:19
Discuss

Hygiene and health company Essity has completed the acquisition of Edgewell Personal Care's feminine care business, including the Carefree, Stayfree and o.b. brands in North America and global feminine care rights for the Playtex brand. The purchase price for the assets amounts to USD 340m (approximately SEK 3bn) on a cash and debt-free basis. The acquisition supports Essity's strategy to focus on high margin categories and to grow market positions in the US, the world's largest hygiene market. 

The completed asset deal includes a broad product portfolio of liners, pads and tampons under well-known brands in the US, Canada, and the Caribbean as well as a production facility in Dover, Delaware. The operations will be consolidated into Essity's accounts as of February 2, 2026.

"As we finalize this acquisition, we look forward to accelerating the growth of these well-known brands using our established recipe for success within Feminine Care. This strengthens Essity's personal care business in North America and supports our ambition to grow in high yielding categories and key geographies," says Ulrika Kolsrud, President and CEO of Essity.

Essity is a fast-growing player in the feminine care category, with several strong regional brands such as Libresse, Bodyform, Nana, Saba, Libra, Nosotras, Knix and Modibodi offering a broad product portfolio of pads, liners, tampons, intimate soaps, intimate wipes, leakproof apparel and menstrual cups.  

Contact information
Sandra Åberg, Vice President Investor Relations, Tel: +46 (0) 70 564 96 89, sandra.aberg@essity.com 
Per Lorentz, Vice President Corporate Affairs, Tel: +46 (0) 73 313 30 55, per.lorentz@essity.com